Gilead poaches Genentech oncology exec

Gilead Sciences Inc. (NASDAQ:GILD) hired Phillipe Bishop as SVP of hematology and oncology therapeutics. Bishop had been VP of product development and oncology at the Genentech Inc. unit of Roche (SIX...